Dr. Disselhoff is a consultant to Pharmaceutical Industry, specializing in Strategic Regulatory Affairs, Quality Management, Organizational Development and Change Management. She has almost 30 years of experience in Pharmaceutical Industry in Regulatory Affairs, Quality Management and Clinical Research.

Truus Janse-de Hoog, Pharm D, retired recently after having served the Dutch Medicines Evaluation Board (MEB) for nearly 25 years. Truus has extensive international experience serving two terms as chair of Coordination group for human medicines (CMDh) (2005-2008; 2008-2011). From 2006 to 2013 she served as co-chair of the joint HMA/EMA Taskforce on Transparency.